INTRODUCTION
Hypertension remains the most common, readily identifiable and reversible risk factor for myocardial infarction, stroke, heart failure, atrial fibrillation, aortic dissection and peripheral arterial disease. The global burden of hypertension is rising and projected to affect 1.5 billion persons by the year 2025 which is one third of the world's population. 1 Diastolic dysfunction is now well established as a cause of left sided heart failure and as a powerful predictor of cardiovascular events. Diastolic dysfunction is present in over 25% of adults over 40 years of age and accounts for approximately 50% of heart failure cases.
(eg. atrial fibrillation), obesity, diabetes mellitus, renal dysfunction (creatinine clearance <90ml/ hour), sleep apnoea, hypertrophic cardiomyopathy, valvular heart disease and constrictive pericarditis were excluded from the study. . A verbal consent was taken from the patient for the data collection regarding systemic hypertension, performing transthoracic echocardiography (2D) for assessing LV diastolic function. Data collection Data collection was done as per predefined and tested structured proforma. The datas were regularly entered and analyzed in SPSS software. A total of recently detected 120 hypertensive patients were included in the study.
Statistical analysis
For descriptive data ratio, mean and standard deviation were calculated and for qualitative data like the possible association between risk factor and development of LVDD will be tested using chi square and students paired t test as applicable. Univariate and multivariate logistic regression analysis were done to evaluate the association of HTN and/or multiple risk factors to that of LVDD. Ethical clearance was obtained from the Institutional review board of College of Medical Sciences-Bharatpur, Chitwan, Nepal.
RESULTS

Characteristics of the Subjects
The age of the patients in our study ranged from 20 to 84 years with mean age of 5oyears±14.13 years (standard deviation). Females constituted 51 in number (42.5%) whereas males were 69 (57.5%) with male:female ratio being 1.35:1. Majority of the patients (44.17%) in this study belonged to 45-64 years of age followed by 25-44 years (34.17%) and the least among less than 25 years (5.00%). The age-wise distribution of the patients with gender is illustrated in the Table1. Out of the total hypertensives, accelerated HTN was recorded in 15.83% patients, isolated systolic HTN in 9.17%, isolated diastolic HTN in 7.50% and hypertensive crisis in 6.67% as shown below in the Table 2 . In this study, the majority of the patients(40 in number:33.33%) were clinically asymptomatic. 37 patients(30.83%) presented with mild headache and dizziness, 13 patients(10.83%) had palpitation and 12 patients(10%) had mild atypical chest pain with exertional shortness of breath, NYHA-Class II. The following table shows the various assessment parameters of LVDD observed in our study. The value depicted below in Table 3 is the average
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Laudari S, et al. II HTN) . The association between stages of systemic HTN and LVDD was found to be highly statistically significant (p=0.002). Concentric LVH was detected in 22 (18.33%) patients in our study.
DISCUSSION
A total of 120 patients were included in our study, the age ranging from 20 to 84 years with mean age 10 .83% patients had Grade II LVDD, only 2.50% had non-restrictive Grade III LVDD and none had LVDD-IV. In a similar study by Masliza, Daud and Khalid4 including 396 subjects, patients with newly diagnosed hypertensives (NDHT) had reduced E/A ratio and shortened deceleration time. The peak A velocity and isovolumetric relaxation time (IVRT) were increased in the newly diagnosed hypertensive (NDHT) group. The prevalence of diastolic dysfunction was increased in the NDHT group, 18.6% vs 3.4%,P < 0.001. Of the 32 NDHT subjects who had diastolic dysfunction, 84.4% (27) had no left ventricular hypertrophy (LVH) and 15.7% (5) had LVH. In a study from India by Mukesh Laddha, Vishal Sachdeva, PM Diggikar, PK Satpathy and AL Kakrani 5 (2014), diastolic dysfunction (assessed by E/A ratio) was present in 61.4% of patients. In the Hypertension Genetic Epidemiology Network (Hyper GEN) study6, 515 males and 839 females, mostly treated (95%) hypertensive participants were enrolled. Mitral E-wave and Awave velocities (p <0.001) were lower in men than in women, but the mitral E/A ratio and atrial filling fraction were nearly identical in both genders. Deceleration time (p-0.018) and isovolumic relaxation time (IVRT) were longer in men than in women (p <0.001). Prolonged IVRT was present in more men than women (14% vs 7%, p <0.05). The overall prevalence of diastolic abnormalities, as defined by the European Study Group7 on Diastolic Heart Failure i.e. age dependent isovolumic relaxation time (92-105 ms) and early (E-wave) and late (A-wave) left ventricular filling (E/A-ratio, 1-0.5) was 11.1%. The prevalence of diastolic abnormalities varied according to age: from 2.8% in individuals aged 25-35 years to 15.8% among those older than 65 years (P<0.01). Significantly higher rates of diastolic abnormalities were observed in men as compared to women (13.8% vs 8.6%, P<0.01). 9 in children with systemic hypertension emphasized the presence of diastolic dysfunction even in the absence of LVH. In the Olmsted County Heart Function Study10, a cohort of 2042 persons 45 years or older had been evaluated for diastolic function (examination 1:1997-2000) and same group were re-evaluated in examination two (2001) (2002) (2003) (2004) ). The cohort was followed passively and incident heart failure events ascertained (2004) (2005) (2006) (2007) (2008) (2009) (2010) . During the four years between examinations one and two, diastolic dysfunction prevalence increased from 23.8% to 39.2% (P<0.001). Diastolic function grade worsened in 23.4% of participants, was unchanged in 67.8% and improved in 8.8%. Worsened diastolic dysfunction was associated with age 65 years or older. Inflammation has been proposed to be a common pathway through which conditions like HTN and DM lead to ventricular stiffness and DD and eventually to decompensated heart failure.
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The data presented, thus far, offers compelling evidence to support an association between inflammation and hypertension. However, there is accumulating data from the current medical literature to suggest that it is not only blood pressure reduction per se but the way in which Original Research Article Laudari S, et al
